Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Discontinued Operations (Tables)

v3.8.0.1
Note 3 - Discontinued Operations (Tables)
 9 Months Ended
Sep. 30, 2017
Notes Tables  
Disposal Groups, Including Discontinued Operations [Table Text Block]
   
September
30
,
2017
    
December 31,
2016
  
Accounts and other receivables
   $
—
     $
1,598,994
  
Inventory, net
    
—
      
1,374,618
  
Prepaid expenses
    
—
      
170,635
  
Assets associated with discontinued operations, current
    
—
      
3,144,247
  
Property and equipment, net of accumulated depreciation
    
—
      
70,973
  
Patents and trademarks, net of accumulated amortization
    
—
      
34,282
  
Assets associated with discontinued operations, noncurrent
    
—
      
105,255
  
Total a
ssets associated with discontinued operations
   $
—
     $
3,249,502
  
                 
Accounts payable
   $
232
     $
1,957,938
  
Accrued liabilities
    
32,909
      
607,659
  
Deferred revenue
    
—
      
2,300,000
  
Liabilities
associated with discontinued operations, current
   $
33,141
     $
4,865,597
  
   
Three Months Ended
September
30,
    
Nine
Months Ended
September
30,
  
   
2017
    
2016
    
2017
    
2016
  
Revenue:
                                
Lymphoseek sales revenue
   $
—
     $
6,672,489
     $
2,917,213
     $
14,673,689
  
Grant and other revenue
    
—
      
385
      
—
      
575
  
Total revenue
    
—
      
6,672,874
      
2,917,213
      
14,674,264
  
Cost of goods sold
    
—
      
918,928
      
364,192
      
2,012,301
  
Gross profit
    
—
      
5,753,946
      
2,553,021
      
12,661,963
  
Operating expenses:
                                
Research and development
    
(5,951
)
    
356,612
      
382,070
      
1,450,231
  
Selling, general and administrative
    
—
      
1,129,093
      
805,464
      
4,092,951
  
Total operating expenses
    
(5,951
)
    
1,485,705
      
1,187,534
      
5,543,182
  
Income from discontinued operations
    
5,951
      
4,268,241
      
1,365,487
      
7,118,781
  
Interest expense
    
—
      
(2,566,330
)
    
(1,718,506
)
    
(12,286,093
)
Income (l
oss) before income taxes
    
5,951
      
1,701,911
      
(353,019
)
    
(5,167,312
)
Benefit from (provision for) income taxes
    
(552
 )    
—
      
20,181
      
—
  
Income (l
oss) from discontinued operations
   $
5,399
     $
1,701,911
     $
(332,838
)
   $
(5,167,312
)